SCHEMBL314693

SCHEMBL314693

C[C@@H]1CNc2cc(Cl)ccc2-n2c(-c3cccc(Br)c3)nnc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
TP53 P04637 1/20 0.35
HPGD P15428 2/20 0.34
AVPR1A P37288 1/20 0.34
BRD4 O60885 7/20 0.34
GCGR P47871 1/20 0.34
MAPK14 Q16539 1/20 0.34
CYP1A2 P05177 1/20 0.33
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
LMNA P02545 1/20 0.33
GABRA1 P14867 1/20 0.33
CNR1 P21554 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL314692 1.00 ALDH1A1 (0.36) ALDH1A1TP53HPGDAVPR1ABRD4
SCHEMBL314694 1.00 ALDH1A1 (0.36) ALDH1A1TP53HPGDAVPR1ABRD4
SCHEMBL315183 0.91 TP53 (0.43) ALDH1A1TP53HPGDAVPR1ABRD4
SCHEMBL315182 0.91 TP53 (0.43) ALDH1A1TP53HPGDAVPR1ABRD4
SCHEMBL315184 0.91 TP53 (0.43) ALDH1A1TP53HPGDAVPR1ABRD4
SCHEMBL314491 0.90 ALDH1A1 (0.41) ALDH1A1TP53HPGDAVPR1ABRD4
SCHEMBL314492 0.90 ALDH1A1 (0.41) ALDH1A1TP53HPGDAVPR1ABRD4
SCHEMBL314493 0.90 ALDH1A1 (0.41) ALDH1A1TP53HPGDAVPR1ABRD4
SCHEMBL314679 0.88 HSD11B1 (0.41) TP53HPGDAVPR1ABRD4GLA
SCHEMBL314677 0.88 HSD11B1 (0.41) TP53HPGDAVPR1ABRD4GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093240-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2012-01-10 US claimed
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP claimed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US claimed
US-8093240-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2012-01-10 US disclosed
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP disclosed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306042-A1 Triazole Derivatives TGFBR1, TGFBR2, SMAD3 ALDH1A1 2295/4885TP53 293/4885HPGD 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.